Page last updated: 2024-10-25

cisapride and Hepatitis C, Chronic

cisapride has been researched along with Hepatitis C, Chronic in 2 studies

Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.

Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nightingale, SL1
Nishiguchi, S1
Shiomi, S1
Kurooka, H1
Iwata, Y1
Sasaki, N1
Tamori, A1
Habu, D1
Takeda, T1
Kawabe, J1
Ochi, H1

Trials

1 trial available for cisapride and Hepatitis C, Chronic

ArticleYear
Randomized trial assessing gastric emptying in patients with chronic hepatitis C during interferon-alpha or -beta therapy and effect of cisapride.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:1

    Topics: Adult; Cisapride; Digestive System; Female; Gastric Emptying; Gastrointestinal Agents; Hepatitis C,

2002

Other Studies

1 other study available for cisapride and Hepatitis C, Chronic

ArticleYear
From the Food and Drug Administration.
    JAMA, 1998, Aug-05, Volume: 280, Issue:5

    Topics: Allergens; Antiviral Agents; Cisapride; Contraindications; Desensitization, Immunologic; Drug Labeli

1998